| |
| Device | MiniMed 670G System, MiniMed 770G System |
| Generic Name | Automated insulin dosing device system, single hormonal control |
| Applicant | Medtronic Minimed, Inc. 18000 Devonshire St. Northridge, CA 91325 |
| PMA Number | P160017 |
| Supplement Number | S089 |
| Date Received | 12/17/2020 |
| Decision Date | 04/19/2021 |
| Product Code |
OZP |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT02130284
|
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Postapproval Study Protocol |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval to introduce the MiniMed 770G System to the post-approval study and to provide protocol updates to meet enrollment requirements. |
| Post-Approval Study | Show Report Schedule and Study Progress |